GlassScriptPhysician profile
Vinicio Hernandez
NPI 1154312783
$42,682.35
in general payments reported to CMS, 2019-2025
97 companies · $4,654 in 2025
The $4,654 reported for 2025 was more than what 81% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,215 · 2020: $5,245 · 2021: $6,628 · 2022: $10K · 2023: $8,116 · 2024: $4,326 · 2025: $4,654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,480 · Travel and Lodging: $1,205 · Education: $570 · Long Term Medical Supply Or Device Loan: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,592.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,480.00 |
| Travel and Lodging | $1,205.36 |
| Education | $569.88 |
| Long Term Medical Supply Or Device Loan | $249.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $6,287.66 | 2019-2025 | Provenge |
| Novartis Pharmaceuticals Corporation | $5,961.53 | 2019-2025 | Piqray, Kisqali |
| Exelixis INC. | $4,427.87 | 2019-2025 | Cabometyx |
| Janssen Biotech, INC. | $1,906.70 | 2019-2025 | Erleada, Imbruvica, Rybrevant |
| Pfizer INC. | $1,816.42 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,799.80 | 2019-2025 | Enhertu, Imfinzi, Lynparza |
| Astellas Pharma US INC | $1,561.43 | 2019-2025 | Xtandi, Padcev, Vyloy |
| Bayer Healthcare Pharmaceuticals INC. | $1,109.00 | 2019-2025 | |
| Celgene Corporation | $1,100.42 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Merck Sharp & Dohme LLC | $1,094.53 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Daiichi Sankyo INC. | $894.88 | 2019-2025 | Enhertu, Injectafer, Datroway |
| E.R. Squibb & Sons, L.L.C. | $833.81 | 2019-2025 | Reblozyl, Opdivo, Eliquis |
| Seagen INC. | $806.56 | 2019-2023 | Tukysa, Adcetris |
| Lilly USA, LLC | $701.78 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Eisai INC. | $618.12 | 2019-2025 |
Show all 97 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $595.94 | 2021-2025 | |
| Gilead Sciences, INC. | $594.93 | 2021-2025 | Trodelvy |
| Incyte Corporation | $561.11 | 2020-2025 | Jakafi, Monjuvi, Zynyz |
| Jazz Pharmaceuticals INC. | $499.45 | 2020-2025 | |
| Array Biopharma INC | $482.43 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Glaxosmithkline, LLC. | $475.36 | 2020-2025 | Ojjaara, Blenrep, Shingrix |
| Taiho Oncology, INC. | $432.65 | 2019-2025 | |
| Karyopharm Therapeutics INC. | $424.30 | 2020-2025 | Xpovio |
| Genentech USA, INC. | $338.55 | 2019-2024 | Venclexta, Polivy, Phesgo |
| Genzyme Corporation | $327.54 | 2019-2025 | |
| Beigene USA, INC. | $327.44 | 2022-2025 | Brukinsa, Tevimbra |
| Emd Serono, INC. | $303.86 | 2019-2025 | Tepmetko, Bavencio |
| Sobi, INC | $300.56 | 2022-2025 | |
| Tersera Therapeutics LLC | $274.31 | 2023-2025 | Zoladex, Quzyttir, Xermelo |
| Dova Pharmaceuticals | $260.16 | 2019-2021 | |
| Kite Pharma, INC. | $257.61 | 2021-2024 | Yescarta |
| Regeneron Healthcare Solutions, INC. | $235.02 | 2019-2023 | Libtayo |
| Sun Pharmaceutical Industries INC. | $227.81 | 2019-2023 | Odomzo, Yonsa |
| Clovis Oncology, INC. | $222.29 | 2019-2022 | |
| Pharmacyclics LLC, An Abbvie Company | $220.41 | 2019-2022 | |
| Amgen INC. | $210.11 | 2019-2022 | |
| Tempus Ai, INC | $206.19 | 2024-2025 | Xt Cdx |
| Beone Medicines USA, INC. | $199.97 | 2025 | Brukinsa, Tevimbra |
| Aveo Pharmaceuticals, INC. | $188.82 | 2022-2025 | |
| Kyowa Kirin, INC. | $187.58 | 2019-2025 | |
| Stemline Therapeutics INC. | $165.46 | 2023-2025 | Orserdu |
| Servier Pharmaceuticals LLC | $158.86 | 2021-2025 | |
| Myovant Sciences INC. | $151.11 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.61 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $137.84 | 2023-2024 | Fruzaqla, Alunbrig, Vpriv |
| Alexion Pharmaceuticals, INC. | $130.24 | 2020-2025 | Ultomiris |
| Puma Biotechnology, INC. | $128.76 | 2020-2025 | Nerlynx |
| Agios Pharmaceuticals, INC. | $128.06 | 2020-2025 | Pyrukynd |
| Intuitive Surgical, INC. | $121.39 | 2022 | |
| Global Blood Therapeutics, INC. | $114.48 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $106.60 | 2023-2024 | Orgovyx |
| Tolmar Pharmaceuticals, INC. | $103.16 | 2020-2022 | |
| Pharmacosmos Therapeutics INC. | $93.59 | 2021-2024 | Monoferric, Cosela |
| Morphosys, US INC. | $93.38 | 2021-2022 | |
| Emmaus Medical, INC. | $91.09 | 2019-2022 | |
| Heron Therapeutics, INC. | $82.65 | 2022 | |
| Pharmaessentia USA Corporation | $79.51 | 2024-2025 | Besremi |
| Lexicon Pharmaceuticals, INC. | $79.13 | 2019-2020 | |
| G1 Therapeutics, INC. | $78.60 | 2022-2023 | Cosela |
| Amneal Pharmaceuticals LLC | $76.16 | 2023-2024 | Avastin |
| Epizyme, INC. | $70.19 | 2021-2022 | |
| Foundation Medicine, INC. | $70.19 | 2021-2023 | |
| Novocure INC. | $67.16 | 2025 | Optune Lua (Novottf-200t) |
| Azurity Pharmaceuticals, INC. | $52.25 | 2024-2025 | Danziten, Vivimusta |
| Asd Specialty Healthcare, LLC | $49.79 | 2019 | |
| Cti Biopharma Corp. | $46.71 | 2022-2023 | Vonjo |
| Organon LLC | $37.42 | 2022 | |
| Iovance Biotherapeutics, INC. | $35.73 | 2025 | Amtagvi |
| Mirati Therapeutics, INC. | $34.53 | 2023 | Krazati |
| Tesaro, INC. | $34.05 | 2019 | |
| Alnylam Pharmaceuticals INC. | $33.17 | 2022-2023 | Givlaari |
| Eusa Pharma (US) LLC | $32.49 | 2019-2022 | |
| Macrogenics, INC. | $32.11 | 2022-2023 | |
| Verity Pharmaceuticals INC. | $31.30 | 2022-2024 | Trelstar |
| Advanced Accelerator Applications | $30.89 | 2019-2020 | |
| Acrotech Biopharma INC. | $28.82 | 2023 | Beleodaq |
| Acceleron Pharma, INC. | $28.80 | 2020-2021 | |
| Legend Biotech USA INC. | $28.56 | 2025 | Carvykti |
| Deciphera Pharmaceuticals INC. | $28.08 | 2020-2021 | |
| Pharmaand Gmbh | $25.55 | 2025 | Rubraca |
| Tolmar, INC. | $25.55 | 2025 | Rubraca, Eligard |
| Recordati_rare_diseases_inc. | $25.26 | 2025 | Enjaymo |
| Ipsen Biopharmaceuticals, INC | $25.13 | 2020 | |
| Corcept Therapeutics | $25.10 | 2025 | Korlym |
| Biocartis US, INC | $24.35 | 2023 | Idylla |
| Aurobindo Pharma USA, INC. | $23.33 | 2019 | |
| Immunomedics, INC. | $21.94 | 2020 | |
| Spectrum Pharmaceuticals INC. | $21.54 | 2025 | Rolvedon |
| Accord Healthcare, INC. | $20.69 | 2023 | |
| Progenics Pharmaceuticals, INC. | $18.70 | 2024 | |
| Ge Healthcare | $17.83 | 2021 | |
| Fennec Pharmaceuticals, INC. | $17.62 | 2024 | Pedmark |
| Portola Pharmaceuticals, LLC | $17.02 | 2019 | |
| West Therapeutics Development, LLC | $16.90 | 2020 | |
| Mayne Pharma Commercial LLC | $15.08 | 2021 | |
| Shire North American Group INC | $14.68 | 2019 | |
| Secura Bio, INC. | $11.25 | 2019 |
Drugs and devices associated with these payments
Cabometyx $3,018Enhertu $595Provenge $585Xtandi $483Nubeqa $473Venclexta $465Lynparza $451Reblozyl $447Keytruda $415Brukinsa $408Lonsurf $327Inqovi $327Kisqali $313Jaypirca $310Verzenio $304Erleada $288Orgovyx $280Imfinzi $268Retevmo $261Talzenna $253Braftovi $236Lorbrena $217Mektovi $212Lenvima $209Ziihera $209Xt Cdx $206Pluvicto $206Imbruvica $203Xpovio $201Ojjaara $200Inlyta $199Elrexfio $193Tukysa $188Stivarga $187Vitrakvi $187Rybrevant $174Orserdu $165Scemblix $160Adcetris $159Promacta $154Vonjo $153Pomalyst $151Fabhalta $143Piqray $138Zoladex $135Jakafi $132Akeega $129Lutathera $127Bosulif $118Trodelvy $116Ultomiris $116Quzyttir $111Ibrance $106Comirnaty $104Zepzelca $99.60Darzalex $97.65Injectafer $97.11Balversa $95.36Tevimbra $94.30Opdivo $88.72Doptelet $81.39Mekinist $80.45Bavencio $80.21Besremi $79.51Padcev $77.79Avastin $76.16Datroway $73.63Optune Lua (Novottf-200t) $67.16Fruzaqla $63.38Monjuvi $62.94Pyrukynd $62.02Tibsovo $61.95Monoferric $61.45Libtayo $60.29Opdualag $58.75Fotivda $57.08Nerlynx $55.72Talvey $55.69Oxbryta $55.16Cosela $53.62Vyloy $52.22Paxlovid $51.97Rubraca $51.10Alunbrig $51.09Tasigna $48.97Enjaymo $44.59Zynyz $41.50Vanflyta $39.05Yonsa $36.63Odomzo $36.63Wayrilz $35.75Amtagvi $35.73Synagis $35.32Krazati $34.53Cablivi $34.14Yescarta $32.96Tafinlar $29.84Tepmetko $29.62Poteligeo $29.48Jevtana $28.86
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinicio Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.